Transamerica Financial Advisors’s West Pharmaceutical WST Stock Holding History

Transamerica Financial Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$87.3K	Buy	243 +169	+228%	+$51.7K	0.01%	616
2026 Q1	$18.6K	Buy	74 +45	+155%	+$11.2K	﹤0.01%	820
2025 Q4	$8K	Sell	29 -7	-19%	-$1.92K	﹤0.01%	884
2025 Q3	$9.19K	Buy	+36	New	+$8.75K	﹤0.01%	744
2024 Q1	–	Sell	-7	Closed	-$3K	–	697
2023 Q4	$3K	Buy	7 +5	+250%	+$1.77K	﹤0.01%	350
2023 Q3	$1K	Hold	2	–	–	﹤0.01%	633
2023 Q2	$1K	Hold	2	–	–	﹤0.01%	605
2023 Q1	$1K	Hold	2	–	–	﹤0.01%	592
2022 Q4	$1K	Sell	2 -1	-33%	-$237	﹤0.01%	679
2022 Q3	$1K	Hold	3	–	–	﹤0.01%	635
2022 Q2	$1K	Buy	+3	New	+$976	﹤0.01%	645
2021 Q3	–	Sell	-1	Closed	-$1K	–	205
2021 Q2	$1K	Buy	+1	New	+$330	0.02%	197

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Transamerica Financial Advisors's WST Position: Q2 2026 in Review

Transamerica Financial Advisors increased its West Pharmaceutical (WST) stake by 228% in Q2 2026, buying an estimated $51.7K and bringing the position to 243 shares worth $87.3K. The position accounts for 0.01% of the portfolio, ranked #616.

Transamerica Financial Advisors first reported a position in WST in Q2 2021 and has held it in 12 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Transamerica Financial Advisors held 243 shares of West Pharmaceutical worth $87.3K as of Q2 2026.
Transamerica Financial Advisors bought 169 West Pharmaceutical shares in Q2 2026, an estimated $51.7K.
West Pharmaceutical made up 0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #616 holding.
Transamerica Financial Advisors first reported a position in West Pharmaceutical in Q2 2021 and has held it in 12 quarters since.
834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.